COMMUNITY HEALTH SYSTEMS INC (CYH)

US2036681086 - Common Stock

3.06  -0.01 (-0.33%)

After market: 3.1 +0.04 (+1.31%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CYH. CYH was compared to 107 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of CYH while its profitability can be described as average. CYH has a valuation in line with the averages, but on the other hand it scores bad on growth.



4

1. Profitability

1.1 Basic Checks

In the past year CYH has reported negative net income.
In the past year CYH had a positive cash flow from operations.
In multiple years CYH reported negative net income over the last 5 years.
Of the past 5 years CYH 4 years had a positive operating cash flow.

1.2 Ratios

CYH has a Return On Assets (-2.86%) which is in line with its industry peers.
CYH's Return On Invested Capital of 5.41% is fine compared to the rest of the industry. CYH outperforms 61.90% of its industry peers.
CYH had an Average Return On Invested Capital over the past 3 years of 6.00%. This is below the industry average of 8.16%.
Industry RankSector Rank
ROA -2.86%
ROE N/A
ROIC 5.41%
ROA(3y)0.3%
ROA(5y)-0.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)6%
ROIC(5y)5.36%

1.3 Margins

With a decent Operating Margin value of 6.43%, CYH is doing good in the industry, outperforming 69.52% of the companies in the same industry.
CYH's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 84.60%, CYH belongs to the best of the industry, outperforming 96.19% of the companies in the same industry.
CYH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.43%
PM (TTM) N/A
GM 84.6%
OM growth 3Y12.48%
OM growth 5Y2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.28%
GM growth 5Y0.16%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CYH is still creating some value.
The number of shares outstanding for CYH has been increased compared to 1 year ago.
Compared to 5 years ago, CYH has more shares outstanding
CYH has about the same debt/assets ratio as last year.

2.2 Solvency

CYH has an Altman-Z score of 0.79. This is a bad value and indicates that CYH is not financially healthy and even has some risk of bankruptcy.
CYH's Altman-Z score of 0.79 is on the low side compared to the rest of the industry. CYH is outperformed by 67.62% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.79
ROIC/WACC0.92
WACC5.86%

2.3 Liquidity

CYH has a Current Ratio of 1.46. This is a normal value and indicates that CYH is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.46, CYH is in line with its industry, outperforming 54.29% of the companies in the same industry.
A Quick Ratio of 1.32 indicates that CYH should not have too much problems paying its short term obligations.
CYH has a Quick ratio (1.32) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.46
Quick Ratio 1.32

3

3. Growth

3.1 Past

CYH shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -296.15%.
Looking at the last year, CYH shows a small growth in Revenue. The Revenue has grown by 0.81% in the last year.
The Revenue has been decreasing by -2.47% on average over the past years.
EPS 1Y (TTM)-296.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y1.94%
Revenue growth 5Y-2.47%
Sales Q2Q%0.13%

3.2 Future

Based on estimates for the next years, CYH will show a very strong growth in Earnings Per Share. The EPS will grow by 32.55% on average per year.
Based on estimates for the next years, CYH will show a small growth in Revenue. The Revenue will grow by 1.86% on average per year.
EPS Next Y60.04%
EPS Next 2Y50.4%
EPS Next 3Y32.55%
EPS Next 5YN/A
Revenue Next Year0.37%
Revenue Next 2Y0.77%
Revenue Next 3Y1.86%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYH. In the last year negative earnings were reported.
CYH is valuated reasonably with a Price/Forward Earnings ratio of 8.40.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CYH indicates a rather cheap valuation: CYH is cheaper than 93.33% of the companies listed in the same industry.
CYH's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.67.
Industry RankSector Rank
PE N/A
Fwd PE 8.4

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CYH indicates a somewhat cheap valuation: CYH is cheaper than 77.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.25

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CYH's earnings are expected to grow with 32.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y50.4%
EPS Next 3Y32.55%

0

5. Dividend

5.1 Amount

No dividends for CYH!.
Industry RankSector Rank
Dividend Yield N/A

COMMUNITY HEALTH SYSTEMS INC

NYSE:CYH (1/6/2025, 5:48:50 PM)

After market: 3.1 +0.04 (+1.31%)

3.06

-0.01 (-0.33%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-23 2024-10-23/amc
Earnings (Next)02-18 2025-02-18/amc
Inst Owners77.58%
Inst Owner Change0%
Ins Owners8.18%
Ins Owner Change0%
Market Cap425.19M
Analysts70.77
Price Target4.88 (59.48%)
Short Float %7.28%
Short Ratio3.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.57%
Min EPS beat(2)-61.65%
Max EPS beat(2)-39.49%
EPS beat(4)1
Avg EPS beat(4)-224.77%
Min EPS beat(4)-812.18%
Max EPS beat(4)14.24%
EPS beat(8)3
Avg EPS beat(8)-102.85%
EPS beat(12)5
Avg EPS beat(12)-612.63%
EPS beat(16)9
Avg EPS beat(16)-176.95%
Revenue beat(2)1
Avg Revenue beat(2)0.02%
Min Revenue beat(2)-0.77%
Max Revenue beat(2)0.8%
Revenue beat(4)2
Avg Revenue beat(4)0.09%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)0.8%
Revenue beat(8)3
Avg Revenue beat(8)-0.02%
Revenue beat(12)4
Avg Revenue beat(12)-0.81%
Revenue beat(16)8
Avg Revenue beat(16)-0.34%
PT rev (1m)-8.37%
PT rev (3m)-7.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)35.05%
EPS NY rev (1m)-4.43%
EPS NY rev (3m)-31.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.67%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.4
P/S 0.03
P/FCF N/A
P/OCF 1.2
P/B N/A
P/tB N/A
EV/EBITDA 9.25
EPS(TTM)-1.02
EYN/A
EPS(NY)0.36
Fwd EY11.9%
FCF(TTM)-0.05
FCFYN/A
OCF(TTM)2.55
OCFY83.26%
SpS90.33
BVpS-13.12
TBVpS-41.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.86%
ROE N/A
ROCE 6.85%
ROIC 5.41%
ROICexc 5.43%
ROICexgc 8.17%
OM 6.43%
PM (TTM) N/A
GM 84.6%
FCFM N/A
ROA(3y)0.3%
ROA(5y)-0.05%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)6%
ROIC(5y)5.36%
ROICexc(3y)6.13%
ROICexc(5y)5.56%
ROICexgc(3y)9.24%
ROICexgc(5y)8.42%
ROCE(3y)7.59%
ROCE(5y)6.79%
ROICexcg growth 3Y10.04%
ROICexcg growth 5Y0.62%
ROICexc growth 3Y12.25%
ROICexc growth 5Y1.11%
OM growth 3Y12.48%
OM growth 5Y2.07%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.28%
GM growth 5Y0.16%
F-Score5
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 8.92
Cap/Depr 75.52%
Cap/Sales 2.88%
Interest Coverage 1.03
Cash Conversion 27.55%
Profit Quality N/A
Current Ratio 1.46
Quick Ratio 1.32
Altman-Z 0.79
F-Score5
WACC5.86%
ROIC/WACC0.92
Cap/Depr(3y)85.68%
Cap/Depr(5y)81.59%
Cap/Sales(3y)3.64%
Cap/Sales(5y)3.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-296.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.09%
EPS Next Y60.04%
EPS Next 2Y50.4%
EPS Next 3Y32.55%
EPS Next 5YN/A
Revenue 1Y (TTM)0.81%
Revenue growth 3Y1.94%
Revenue growth 5Y-2.47%
Sales Q2Q%0.13%
Revenue Next Year0.37%
Revenue Next 2Y0.77%
Revenue Next 3Y1.86%
Revenue Next 5YN/A
EBIT growth 1Y-6.6%
EBIT growth 3Y14.67%
EBIT growth 5Y-0.45%
EBIT Next Year60.86%
EBIT Next 3Y21.54%
EBIT Next 5YN/A
FCF growth 1Y98.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y247.5%
OCF growth 3Y-54.14%
OCF growth 5Y-5.18%